Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ala”

271 pharma patents match "ala" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 4 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "ala" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “ala” · 30,257 patents in full index Clear search

  1. US 10870842

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  2. US 10869865

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Serv · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  3. US 10799511

    Methods for reducing or ameliorating mortality and/or morbidity due to chlorine inhalation

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  4. US 10799713

    Miniature wearable laser treatment device

    Veralase, LLC · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  5. US 10744154

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted

  6. US 10716793

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  7. US 10710958

    Carbamoyl phenylalaninol compounds and uses thereof

    Jazz Pharmaceuticals Ireland Limited · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  8. US 10695308

    Inhalation formulations of treprostinil

    United Therapeutics Corporation · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  9. US 10683316

    Synthetic catalase/superoxide dismutase mimetics and methods for treating viral infections

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  10. US 10653704

    Inhalable formulation

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted

  11. US 10640493

    Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

    The Regents of the University of California · Granted May 5, 2020 · Expires Apr 30, 2040

    granted

  12. US 10632088

    Inactivators of Toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria

    Northwestern University · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  13. US 10525106

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted

  14. WO 2019224246

    MÉTHODES FONDÉES SUR DES BIOMARQUEURS DESTINÉES AU TRAITEMENT D'UNE MALADIE ATOPIQUE PAR IMMUNOTHÉRAPIE

    ALK ABELLO AS [DK] · Granted Nov 28, 2019 · Expires Nov 23, 2039

    granted

  15. US 10471061

    Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted

  16. US 10449203

    Tianeptine oxalate salts and polymorphs

    TONIX PHARMA LIMITED · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  17. US 10406210

    High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

    Amphastar Pharmaceuticals, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  18. US 10400239

    Compositions and methods for inhibiting expression of the ALAS1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  19. US 10376525

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

  20. US 10342791

    Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

    The United States of America as represented by the Secretary of the Army · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  21. US 10335460

    IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  22. US 10322168

    High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

    Amphastar Pharmaceuticals, Inc. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  23. US 10280160

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted May 7, 2019 · Expires May 2, 2039

    granted

  24. US 10280414

    Stabilized α-galactosidase and uses thereof

    Protalix Ltd. · Granted May 7, 2019 · Expires May 2, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.